Shanghai Henlius Biotech, Inc. (HKG:2696)
61.10
-2.00 (-3.17%)
Jan 21, 2026, 3:05 PM HKT
Shanghai Henlius Biotech Employees
Shanghai Henlius Biotech had 3,515 employees as of December 31, 2024. The number of employees decreased by 122 or -3.35% compared to the previous year.
Employees
3,515
Change (1Y)
-122
Growth (1Y)
-3.35%
Revenue / Employee
1.80M HKD
Profits / Employee
255.37K HKD
Market Cap
34.29B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 3,515 | -122 | -3.35% |
| Dec 31, 2023 | 3,637 | 231 | 6.78% |
| Dec 31, 2022 | 3,406 | 1,172 | 52.46% |
| Dec 31, 2021 | 2,234 | 361 | 19.27% |
| Dec 31, 2020 | 1,873 | 701 | 59.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| 3SBio | 5,577 |
| Genscript Biotech | 5,568 |
| RemeGen | 2,999 |
| Shanghai Junshi Biosciences | 2,578 |
| Zai Lab | 1,869 |
| Keymed Biosciences | 1,258 |
| Biocytogen Pharmaceuticals (Beijing) | 1,117 |
| InnoCare Pharma | 1,089 |